AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,295 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
¿Qué tal es el rendimiento del precio de la acción ADDLIFE AB?
El precio actual de ADDLIFE AB es de $42, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de AddLife AB (publ)?
AddLife AB (publ) pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de AddLife AB (publ)?
La capitalización bursátil actual de AddLife AB (publ) es $4.9B
¿Es AddLife AB (publ) una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 5 analistas han realizado calificaciones de análisis para AddLife AB (publ), incluyendo 1 fuerte compra, 3 compra, 2 mantener, 0 venta, y 1 fuerte venta